ARWR
ARROWHEAD PHARMACEUTICALS, INC.
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) has 8 SEC Form 4 filings (51 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jun 18, 2026.
The most active filer is Chief Executive Officer Anzalone Christopher Richard with 5 filings. Insiders have net sold $8.3M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Christopher R. Anzalone
- Employees:609
- HQ:Pasadena, CA, US
- IPO:1993-12-16
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$26.1M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$10.1B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Lu HongboFirst filing | Director | Sale | 2,970 | $228K | May 14 | SEC ↗ |
O'Brien PatrickFirst filing | COO | Sale | 49,493 | $3.1M | Jan 5 | SEC ↗ |
Hamilton James CFirst filing | Chief Medical Officer | Sale | 40,164 | $2.5M | Jan 5 | SEC ↗ |
| Chief Executive Officer | Sale | 13,445 | $910K | Dec 23 | SEC ↗ | |
| Chief Executive Officer | Sale | 12,586 | $861K | Dec 23 | SEC ↗ | |
Vakiener VictoriaFirst filing | Director | Sale | 10,040 | $679K | Dec 23 | SEC ↗ |
| Chief Executive Officer | Sale | 85,000 | $5.4M | Dec 19 | SEC ↗ | |
Anzalone Christopher RichardFirst filing | Chief Executive Officer | Sale | 130,000 | $9.0M | Dec 16 | SEC ↗ |
Anzalone Christopher RichardFirst filing | Chief Executive Officer | Sale | 54,298 | $3.4M | Dec 16 | SEC ↗ |
Related companies
ARROWHEAD PHARMACEUTICALS, INC. is in the Healthcare sector.